ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 182,100
-8,300 (-4.36%)
At close: Dec 17, 2025
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 10.5 trillion as of December 17, 2025. Its market cap has increased by 615.04% in one year.
Market Cap
10.50T
Enterprise Value
10.41T
Revenue
88.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
182,100.00
Market Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 10.50T, an increase of 1,624.55%. That is a compound annual growth rate of 50.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 10.50T | 627.04% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | 1.44T | 31.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.03T |
| Celltrion | 41.09T |
| ALTEOGEN | 23.32T |
| SK Biopharmaceuticals | 10.55T |
| Yuhan | 8.71T |
| LigaChem Biosciences | 6.48T |
| Peptron | 6.28T |
| HLB Co., Ltd. | 6.19T |